(Q34621619)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

0 references

1 reference

1 reference

1 reference

James Scheiman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Manuela F Berger

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ha Nguyen

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Jay L Goldstein

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

English

0 references

publication date

16 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

9736

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

173-179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

Summing the risk of NSAID therapy

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Ag

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Visible small-intestinal mucosal injury in chronic NSAID users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Intestinal permeability in the pathogenesis of NSAID-induced enteropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Confidence bands for the difference of two survival curves under proportional hazards model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Anemia in old age is associated with increased mortality and hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960673-3

7 January 2021

10.1016/S0140-6736(10)60673-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20638563%20AND%20SRC:MED&resulttype=core&format=json

release_yol6mh6jh5bplh2b6xg7pgbfue

8 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yol6mh6jh5bplh2b6xg7pgbfue

24 November 2022

mapped directly with Wikidata item

1 reference